Low plasminogen activator inhibitor-1 levels in thyroid carcinoma: uPA/PAI-1 paradox in cancer proggression

Journal Title: JOURNAL OF CONTEMPORARY MEDICINE - Year 2017, Vol 7, Issue 2

Abstract

Aim: Plasminogen activator inhibitor-1 (PAI-1) potently inhibits cell migration and apoptosis. Increased levels of PAI-1 were demonstrated in a great variety of cancers. Many studies demonstrated increased expression of PAI-1 in thyroid cancer and its relation to unfavorable clinical outcome. In this study, we aimed to investigate serum PAI-1 levels in patients with papillary thyroid carcinoma (PTC) as well as its effect in development and size of PTC.Material and methods: Fifty-four papillary thyroid cancer patients (7 male, 47 female) and 24 healthy controls (6 male, 18 female) were enrolled in the study. Groups were compared by demographic, anthropometric, biochemical data, and by serum ghrelin levels. Serum PAI-1 levels were measured by enzyme-linked immunosorbent assay (ELISA).Results: Mean age were similar between PTC and control group (42.4 ± 10.1 to 42.5 ± 8.9, p:0.794). Serum PAI-1 levels were lower in patients with PTC when compared to healthy controls (241.34 ± 107.82 to 327.24 ± 138.51, p:0.011). BMI, Homa-IR and TSH, FT4, anti-TPO, anti-Tg, total cholesterol, triglyceride, HDL-Cholesterol, LDL-Cholesterol, calcium, phosphorus, 25-OH-VitD, parathormone, glucose, insülin concentrations were similar between groups (p>0.05). PAI-1 concentrations were not correlated with clinical, biochemical and hormonal parameters except parathormone (PTH) concentrations in PTC group (r:-0.446, p:0.0027).Conclusions: Serum PAI-1 levels were lower in patients with papillary thyroid carcinoma. Our results might support the thesis of PAI-1 is expected to suppress cancer progression due to its ability to inhibit urokinase plasminogen activator activity.

Authors and Affiliations

Bekir Ucan, Muhammed Kizilgul, Mustafa Sahin, Seyda Ozdemir, Erman Cakal

Keywords

Related Articles

Acil Servise Başvuran Hastalarda Post Operatif Komplikasyonların Epidemiyolojik İncelenmesi

Amaç: Bu çalışmanın amacı postoperatif komplikasyonlara bağlı olarak planlanmamış acil servis ziyaretlerinin değerlendirilmesidir. Bu çalışmada  postoperatif komplikasyonlara bağlı klinik ve laboratuvar nedenler ve görül...

Abdominal Computerized Tomography Findings of Synthetic Cannabinoid Intoxication: A Case Report

The aim of this case report is the description of self-limiting and completely reversible abdominal findings using multi-detector computerized tomography (MDCT) in case of acute Synthetic cannabinoid (SC) intoxication. S...

Hemşirelerin Hastanede Yatan Çocuğun Bakımına Ebeveyn Katılımı Hakkında Görüşleri

Amaç: Çocuk kliniklerinde çalışan hemşirelerin hastanede yatan çocuğun bakımına ebeveyn katılımı hakkında görüşlerinin belirlenmesidir. Yöntem: Tanımlayıcı tipte yapılan araştırma Konya şehir merkezinde bulunan dört...

The approach of ischemic colitis case followed by the lower gastrointesitnal bleeding bleeding

Colonic vascular ischemia is commonly seen in the descending colon and causes malnutrition and is to be commensurate with the duration of clinical myocardial ischemia. History of cerebrovascular disease, hypertension, wi...

Clinical characteristics in children with celiac disease: a single center results

AbstractAim: Celiac disease is an immune-mediated systemic disorder elicited by the ingestion of gluten in genetically susceptible individuals. Gluten-free diet is the basis of treatment. In our study, it was aimed to ev...

Download PDF file
  • EP ID EP423297
  • DOI 10.16899/gopctd.316172
  • Views 121
  • Downloads 0

How To Cite

Bekir Ucan, Muhammed Kizilgul, Mustafa Sahin, Seyda Ozdemir, Erman Cakal (2017). Low plasminogen activator inhibitor-1 levels in thyroid carcinoma: uPA/PAI-1 paradox in cancer proggression. JOURNAL OF CONTEMPORARY MEDICINE, 7(2), 120-125. https://europub.co.uk/articles/-A-423297